Anti-Human CD21 (BU32) Mouse IgG1 Recombinant Antibody, PBS Only
CD21 Uni-rAbTM Recombinant Antibody for FC
Host / Isotype
Mouse / IgG1
Reactivity
Human
Applications
FC
Conjugate
Unconjugated
CloneNo.
BU32
Cat no : 65512-1-PBS
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | human PBMCs |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. |
Product Information
65512-1-PBS targets CD21 in FC applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG1 |
Class | Recombinant |
Type | Antibody |
Immunogen | N/A |
Full Name | complement component (3d/Epstein Barr virus) receptor 2 |
Calculated Molecular Weight | 1092 aa, 119 kDa |
GenBank Accession Number | BC136394 |
Gene Symbol | CD21 |
Gene ID (NCBI) | 1380 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Affinity purification |
Storage Buffer | PBS only |
Storage Conditions | Store at -80°C. Stable for one year after shipment. |
Background Information
CD21, also known as complement receptor type 2 (CR2), complement C3d receptor, and Epstein-Barr virus receptor, is a transmembrane protein that contains a small cytoplasmic domain, a transmembrane region and an extracellular domain consisting of 15 tandem short consensus repeat sequences (PMID: 6230668; 2551147). It is expressed on B cells, follicular dendritic cells, thymocytes and a subset of peripheral T cells (PMID: 26119182). CD21 binds complement fragments C3d, C3dg and iC3b and acts as a receptor for the Epstein-Barr virus (PMID: 7753047). On B cells, together with CD19 and CD81, CD21 forms a complex that functions as a co-receptor to the BCR (PMID: 7542009). It is involved in B cells activation and functions.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for CD21 antibody 65512-1-PBS | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |